Fungal transformations of antihistamines: Metabolism of cyprobeptadine hydrochloride by Cunninghamella elegans

Xenobiotica

Volumn 27, Issue 3, 1997, Pages 301-315

  Zhang, Donglu ^a   Hansen Jr , Eugene B ^a   Deck, Joanna ^a   Heinze, Thomas M ^a   Henderson, Allison ^a   Korfmacher, Walter A ^a,b   Cerniglia, Carl E ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CYPROHEPTADINE; DRUG METABOLITE;

ARTICLE; BIOTRANSFORMATION; CELL CULTURE; DRUG IDENTIFICATION; DRUG METABOLISM; ENZYME ACTIVITY; FUNGUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; ISOTOPE LABELING; MASS; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS;

BIOTRANSFORMATION; CELL-FREE SYSTEM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYPROHEPTADINE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HISTAMINE H1 ANTAGONISTS; HYDROXYLATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MUCORALES; OXYGEN ISOTOPES; SPECTROPHOTOMETRY, ULTRAVIOLET;

CUNNINGHAMELLA ELEGANS; FUNGI;

EID: 0030935426     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982597240622     Document Type: Article

References (34)

1. CERNIGLIA, C. E., 1984, Microbial metabolism of polycyclic aromatic hydrocarbons. Advanced Applied Microbiology, 30, 31-71.
2. CERNIGLIA, C. E., 1993, Biodegradation of polycyclic aromatic hydrocarbons. Current Opinion in Biotechnology, 4, 331-338.
3. CERNIGLIA, C. E. and GIBSON, G. T., 1978, Metabolism of naphthalene by cell-extract of Cunninghamella elegans. Archives in Biochemistry and Biophysics, 186, 121-127.
4. CHOW, S. A. and FISCHER, L. J., 1987, Metabolism and disposition of cyproheptadine and desmethylcyproheptadine in pregnant and fetal rats. Drug Metabolism and Disposition, 15, 740-748.
5. CHOW, S. A., RICKERT, D. K. and FISCHER, L. J., 1988, Evidence that drug metabolites are involved in cyproheptadine-induced loss of pancreatic insulin. Journal of Pharmacology and Experimental Therapeutics, 246, 143-149.
6. CLARK, A. M. and HUFFORD, C. D., 1991, Use of microorganisms for the study of drug metabolism: an update. Medical Research Reviews, 11, 473-501.
7. DAVIS, P. J., 1988, Microbial models of mammalian drug metabolism. Developmental Industrial Microbiology, 29, 197-219.
8. DOERGE, R. F., 1977, Histamine and antihistamine agents. In Textbook of Organic Medicinal and Pharmaceutical Chemistry, edited by C. O. Wilson, O. Gisvold and R. F. Doerge (Philadelphia: J. B. Lippincott), pp. 648-670.
9. 1H NMR spectroscopy. Comparative analysis of mutagenicity. Chemical Research in Toxicology, 7, 352-357.
10. FERRIS, J. P., MACDONALD, L. H., PATRIE, M. A. and MARTIN, M. A., 1976, Aryl hydrocarbon hydroxylase activity in the fungus Cunninghamella bainieri: evidence for the presence of cytochrome P450. Archives in Biochemistry and Biophysics, 175, 443-452.
11. FRIGERIO, A., CAVO-BRIONES, M. and BELVEDERE, G., 1976, Formation of stable epoxides in the metabolism of tricyclic drugs. Drug Metabolism Reviews, 5, 197-218.
12. GUENGERICH, F. P. and MACDONALD, T. L., 1990, Mechanisms of cytochrome P450 catalysis. FASEB Journal, 4, 2453-2459.
13. HANSEN, E. B. JR, CERNIGLIA, C. E., KORFMACHER, W. A., MILLER, D. M. and HEFLICH, R. F., 1987, Microbial transformation of the antihistamine pyrilamine maleate: formation of potential mammalian metabolites. Drug Metabolism and Disposition, 15, 97-106.
14. HANSEN, E. B. JR, SELBY, A. L., CERNIGLIA, C. E., GETEK, T. A. and KORFMACHER, W. A., 1990, Utility of high performance liquid chromatography thermospray mass spectrometry for the characterization of cyproheptadine and its microbial metabolites. Proceedings of the 38th ASMS Conference on Mass Spectrometry and Allied Topics, Tucson, Arizona June 3-8, edited by R. M. Capriole, pp. 994-995.
15. HANSEN, E. B. JR, CHO, B. P., KORFMACHER, W. A. and CERNIGLIA, C. E., 1995, Fungal transformations of antihistamines: metabolism of brompheniramine, chlorpheniramine, and pheniramine to N-oxide and N-demethylated metabolites by the fungus Cunninghamella elegans. Xenobiotica, 25, 1081-1092.
16. HINTZE, K. L., WOLD, J. S. and FISCHER, L. J., 1975, Disposition of cyproheptadine in rats, mice, and humans and identification of a stable epoxide metabolite. Drug Metabolism and Disposition, 3, 1-9.
17. HUCKER, H. B., BALLETTO, A. J., STAUFFER, S. C., ZACCHEI, A. G. and ARISON, B. H., 1974, Physiological disposition and urinary metabolites of cyproheptadine in the dog, rat, and cat. Drug Metabolism and Disposition, 2, 406-415.
18. IWAKI, M., OGISO, T., FUJI, Y., TANINO, T., ITO, Y. and MIKI, Y., 1993, Pharmacokinetics of cyproheptadine and its metabolites in rats. Biological and Pharmaceutical Bulletin, 16, 1276-1281.
19. KORFMACHER, W. A., HOLDER, C. L., CERNIGLIA, C. E., MILLER, D. W., HANSEN, E. B. JR, LAMBERT, K. L., GOSNELL, A. B., SLIKKER, W. JR, RUSHING, L. G. and THOMPSON, H. C. JR, 1985, Desorption chemical ionization mass spectrometry of nine antihistamines and some of their metabolites. Spectroscopy International Journal, 4, 181-192.
20. OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry, 239, 2370-2378.
21. ORTIZ DE MONTELLANO, P. R. and CORREIA, M. A., 1983, Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annual Reviews in Pharmacology and Toxicology, 23, 481-503.
22. ORTIZ DE MONTELLANO, P. R., MATHEWS, J. M. and LANGRY, K. C., 1984, Autocatalytic inactivation of cytochrome P-450 and chloroperoxidase by 1-aminobenzotriazole and other aryne precursors. Tetrahedron, 40, 511-519.
23. PORTER, C. C., ARISON, B. H., GRUBER, V. F., TITUS, D. C. and VANDENHEUVEL, W. J. A., 1975, Human metabolism of cyproheptadine. Drug Metabolism and Disposition, 3, 189-197.
24. RICKERT, D. E. and FISCHER, L. J., 1975, Cyproheptadine and beta cell function in the rat. Insulin secretion from pancreas segments in vitro. Proceedings of Society of Experimental Biology and Medicine, 150, 1-6.
25. SCHLENK, D., BEVERS, R. J., VERTINO, A. M. and CERNIGLIA, C. E., 1994, P450 catalyzed S-oxidation of dibenzothiophene by Cunninghamella elegans. Xenobiotica, 24, 1077-1083.
26. SMITH, R. V. and ROSAZZA, J. P., 1982, Microbial transformations as means of preparing mammalian drug metabolites. In Microbial Transformation of Bioactive Compounds, (edited by J. P. Rosazza Boca Raton: CRC Press), vol. 2, pp. 1-42.
27. STONE, C. A., WENGER, H. C., LUDDEN, C. T., STAVORSKI, J. M. and ROSS, C. A., 1961, Antiserotonin-antihistamine properties of cyproheptadine. Journal of Pharmacology and Experimental Therapeutics, 131, 73-84.
28. WOLD, J. S. and FISCHER, L. J., 1970, The effect of desmethylcyproheptadine on rat and mouse pancreatic islets. Pharmacologist, 12, 218.
29. WONG, Y. W. J. and DAVIS, P. J., 1987, Microbial models of mammalian metabolism: multiple pathway modeling of warfarin metabolism with Cunninghamella elegans. Journal of Pharmaceutical Science, 4, S21.
30. XU, D., VOIGHT, J. M., MICO, B. A., KOMINANI, S., TAKEMORI, S. and COLBY, H. D., 1994, Inhibition of adrenal cytochrome P450 by 1-aminobenzotriazole in vitro. Biochemical Pharmacology, 48, 1421-1426.
31. YANG, W., JIANG, T. and DAVIS, P. J., 1993. Microbial models of mammalian metabolism: Involvement of cytochrome P450 in the N-demethylation of N-methylcarbazole by Cunninghamella echinulata. Xenobiotica, 23, 973-982.
32. ZHANG, D. L., EVANS, F. E., FREEMAN, J. P., DUHART, B. JR and CERNIGLIA, C. E., 1995, Biotransformation of amitriptyline by Cunninghamella elegans. Drug Metabolism and Disposition, 23, 1417-1425.
33. ZHANG, D. L., FREEMAN, J. P., SUTHERLAND, J. B., WALKER, A. E., YANG, Y. and CERNIGLIA, C. E., 1996b, Biotransformation of chlorpromazine and methdilazine by Cunninghamella elegans. Applied and Environmental Microbiology, 62, 798-803.
34. ZHANG, D. L., YANG, Y., LEAKEY, J. E. A. and CERNIGLIA, C. E., 1996a, Phase I and phase II enzymes produced by Cunninghamella elegans for the metabolism of xenobiotics, FEMS Microbiology Letters, 138, 221-226.